Blog
RSS FeedPosted by Michael Wonder on 10 Nov 2020
Mirum Pharmaceuticals broadens Expanded Access Program for maralixibat in Alagille syndrome to Europe and Australia
5 November 2020 - Maralixibat Expanded Access Program now available for patients with pruritus associated with Alagille syndrome in Australia and ...
Posted by Michael Wonder on 08 Nov 2020
Made in Melbourne: lab to start producing promising coronavirus vaccine
8 November 2020 - Global biotech company CSL will begin manufacturing millions of vials of one of the most promising ...
Posted by Michael Wonder on 06 Nov 2020
New drug for gastro-intestinal stromal tumours to be launched in Australia, New Zealand and South East Asia following distribution agreement
5 November 2020 - Qinlock is already approved by the TGA and US FDA. ...
Posted by Michael Wonder on 06 Nov 2020
Clinical Trial Exemption (CTX) scheme renamed as Clinical Trial Approval (CTA) scheme
6 November 2020 - The TGA has changed the name of the Clinical Trial Exemption (CTX) scheme to the Clinical ...
Posted by Michael Wonder on 14 Oct 2020
TGA grants second provisional determination for a COVID-19 vaccine
14 October 2020 - The Therapeutic Goods Administration has granted a provisional determination to Pfizer Australia in relation to its ...
Posted by Michael Wonder on 12 Oct 2020
TGA grants provisional determination for COVID-19 vaccine
9 October 2020 - The Therapeutic Goods Administration has granted a provisional determination to AstraZeneca in relation to its COVID-19 ...
Posted by Michael Wonder on 09 Oct 2020
New transparency measures for prescription medicines
9 October 2020 - The Australian Government has given approval to proceed with two measures to enhance transparency for prescription ...
Posted by Michael Wonder on 08 Oct 2020
CSL confirms UQ vaccine production, trials set for December
8 October 2020 - CSL says it is talking with partner organisations to help roll out doses of the University ...
Posted by Michael Wonder on 08 Oct 2020
Vaccine suppliers given indemnity for 'inevitable' side effects
8 October 2020 - The Morrison government has given the suppliers of two COVID-19 vaccines indemnity against prosecution for rare ...
Posted by Michael Wonder on 08 Oct 2020
Australian Government finalises University of Queensland-CSL COVID-19 vaccine agreement
8 October 2020 - The Australian Government is investing a total of $2.3 billion to support home-grown researchers and manufacturers to ...
Posted by Michael Wonder on 06 Oct 2020
PixCell Medical announces regulatory approval from Australian TGA for HemoScreen point of care hematology analyser
5 October 2020 - PixCell Medical announced today that it has received regulatory approval from the Australian TGA for the ...
Posted by Michael Wonder on 28 Sep 2020
Maritime union rejects claims medical supplies and food are being held up in pay dispute
29 September 2020 - There are fears container ships stuck off the Sydney coast could result in major delays to ...
Posted by Michael Wonder on 27 Sep 2020
Medicine shortage fears amid MUA pay dispute
28 September 2020 - Critical medicines are blocked from entering Australia as the supply chain becomes collateral damage in a wharfie ...
Posted by Michael Wonder on 24 Sep 2020
GW Pharmaceuticals receives Australian Therapeutic Goods Administration approval for Epidyolex (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
23 September 2020 - This represents the third successful regulatory approval globally for GW’s plant-derived cannabis-based medicine. ...
Posted by Michael Wonder on 23 Sep 2020
Australia now eligible to purchase COVID-19 vaccine doses through COVAX
23 September 2020 - The Australian Government has joined the COVAX facility, enabling the purchase of COVID-19 vaccine doses as they ...